Floatz logo

ALECTINIB

Hepatocellular Carcinoma

China Medical University HospitalSmall moleculePhase 1Active
CC
40/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
65/ 100

Competitive context

262 Active assets in the Hepatocellular Carcinoma cohort.

Asset / SponsorPhaseRating
Theprubicin
RWTH Aachen University
Phase 4BB
Ethiodized Oil
RWTH Aachen University
Phase 4BB
Eloxatin
Li Qiang
Phase 4BB
Calcium folinate pentahydrate
Li Qiang
Phase 4BB
FLUOROURACILUM
Li Qiang
Phase 4BB

View all 50 →

Same molecule, other indications

ALECTINIB is also rated in:

non-small cell lung carcinomaDormant
BB
Indicative ·
66 / 100
View asset →
Drug MonitoringDormant
BB
Indicative ·
65 / 100
View asset →
Anaplastic Lymphoma Kinase Gene MutationDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →